ReviewCurrent psychiatry reports2006
Strategies for managing antidepressant-induced sexual dysfunction: a review.
Review in Current psychiatry reports, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 32 citations in OpenAlex.
- Adjuvant administration of probiotic effects on sexual function in depressant women undergoing SSRIs treatment: a double-blinded randomized controlled trial.BMC psychiatry · 2024Trial
- Perspectives on Sexual Health and Function of Recent Male Combat Veterans of Iraq and Afghanistan.Sexual medicine · 2015Article
- [Adverse side-effect on sexual function caused by psychotropic drugs and psychotropic substances].Der Nervenarzt · 2010Article
- Management of hypoactive sexual desire disorder in women: current and emerging therapies.International journal of women's health · 2010Article
- Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.Hormones and behavior · 2010Article
- [Sexual dysfunction in remittent depressive women].Der Nervenarzt · 2009Article
- Clinical applications of centrally acting agents in male sexual dysfunction.International journal of impotence research · 2008Review
- Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy.Current oncology (Toronto, Ont.) · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sexual dysfunction is a common side effect of most antidepressants. Lower rates are reported with some newer agents such as reboxetine and bupropion. The evidence base for its management is limited but growing, with most approaches only tested in a small number of trials. Available strategies include watchful waiting, the use of short drug holidays, and a change of antidepressant. Many specific antidotes have been trialed but with lack of convincing benefit in most cases. However, where antidepressants cause erectile dysfunction, the use of sildenafil has the largest and most consistent evidence base.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.